Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.
作者： D L Healy , H M Fraser , S L Lawson
DOI: 10.1136/BMJ.289.6454.1267
关键词: Internal medicine 、 Uterine fibroids 、 Uterus 、 Peptide hormone 、 Buserelin 、 Endocrinology 、 Uterine Neoplasm 、 Medicine 、 Agonist 、 Leiomyoma 、 In utero
摘要:
sci-hub.se 参考文章(8)
Marco Filicori, Deborah A. Hall, Jacquelyn S. Loughlin, Jean Rivier, Wylie Vale, William F. Crowley, A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogue American Journal of Obstetrics and Gynecology. ,vol. 147, pp. 726- 727 ,(1983) , 10.1016/0002-9378(83)90463-5
F BOURNERIAS, NOMIFENSINE-INDUCED IMMUNE HÆMOLYTIC ANÆMIA AND IMPAIRED RENAL FUNCTION The Lancet. ,vol. 314, pp. 95- 96 ,(1979) , 10.1016/S0140-6736(79)90144-2
H M Fraser, New prospects for luteinising hormone releasing hormone as a contraceptive and therapeutic agent. BMJ. ,vol. 285, pp. 990- 991 ,(1982) , 10.1136/BMJ.285.6347.990
I.A. Sutherland, S. White, G.R. Chambers, D. Rothwell, P.W. Mason, M. Tucker, H.S. Jacobs, A miniature infuser for the pulsatile administration of LHRH Journal of Biomedical Engineering. ,vol. 6, pp. 129- 133 ,(1984) , 10.1016/0141-5425(84)90055-4
Michael R. Soules, Kenneth S. McCarty, Leiomyomas: Steroid receptor content: Variation within normal menstrual cycles American Journal of Obstetrics and Gynecology. ,vol. 143, pp. 6- 11 ,(1982) , 10.1016/0002-9378(82)90676-7
Augusto P. Chong, Michael S. Baggish, Management of pelvic endometriosis by means of intraabdominal carbon dioxide laser. Fertility and Sterility. ,vol. 41, pp. 14- 19 ,(1984) , 10.1016/S0015-0282(16)47533-3
Thomsen P, Jensen Hc, Thomsen F, Liver damage after nomifensine (Alival) Ugeskrift for Læger. ,vol. 143, pp. 1331- 1332 ,(1981)
Littmann Kp, Körst Ha, Brandes Jw, Jaundice following nomifensine Medizinische Welt. ,vol. 31, pp. 1607- ,(1980)